Dr Kevin Keith Toller, MD | |
1120 Neo Loop, Grove, OK 74344 | |
(918) 787-2020 | |
(918) 787-6002 |
Full Name | Dr Kevin Keith Toller |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 30 Years |
Location | 1120 Neo Loop, Grove, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457373466 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 21196 (Oklahoma) | Primary |
207W00000X | Ophthalmology | E2275 (Arkansas) | Secondary |
207W00000X | Ophthalmology | 107786 (Missouri) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Eye Center Pa | 5395713382 | 8 |
News Archive
The researchers examined peer interactions in 63 four-to-six year-old children with mild developmental delays to evaluate their social interactions with other children. They then reevaluated them two years later.
Penn State scientists are the first to observe in living cells a key step in the creation of adenine and guanine, two of the four building blocks that comprise DNA.
New evidence from a large randomized study is answering important questions about the best approach to percutaneous coronary intervention (PCI) in patients with a type of heart attack known as ST-segment-elevation myocardial infarction (STEMI).
Apria Healthcare Group Inc., a quality, cost-efficient provider of home healthcare products and services in the United States, today announced its financial results for the quarter and year ended December 31, 2010.
Investigators have discovered that arsenic in combination with an existing leukemia drug work together to target a master cancer regulator.
› Verified 3 days ago
Entity Name | Eye Center Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629169727 PECOS PAC ID: 5395713382 Enrollment ID: O20040917000683 |
News Archive
The researchers examined peer interactions in 63 four-to-six year-old children with mild developmental delays to evaluate their social interactions with other children. They then reevaluated them two years later.
Penn State scientists are the first to observe in living cells a key step in the creation of adenine and guanine, two of the four building blocks that comprise DNA.
New evidence from a large randomized study is answering important questions about the best approach to percutaneous coronary intervention (PCI) in patients with a type of heart attack known as ST-segment-elevation myocardial infarction (STEMI).
Apria Healthcare Group Inc., a quality, cost-efficient provider of home healthcare products and services in the United States, today announced its financial results for the quarter and year ended December 31, 2010.
Investigators have discovered that arsenic in combination with an existing leukemia drug work together to target a master cancer regulator.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kevin Keith Toller, MD 1120 Neo Loop, Grove, OK 74344 Ph: (918) 787-2020 | Dr Kevin Keith Toller, MD 1120 Neo Loop, Grove, OK 74344 Ph: (918) 787-2020 |
News Archive
The researchers examined peer interactions in 63 four-to-six year-old children with mild developmental delays to evaluate their social interactions with other children. They then reevaluated them two years later.
Penn State scientists are the first to observe in living cells a key step in the creation of adenine and guanine, two of the four building blocks that comprise DNA.
New evidence from a large randomized study is answering important questions about the best approach to percutaneous coronary intervention (PCI) in patients with a type of heart attack known as ST-segment-elevation myocardial infarction (STEMI).
Apria Healthcare Group Inc., a quality, cost-efficient provider of home healthcare products and services in the United States, today announced its financial results for the quarter and year ended December 31, 2010.
Investigators have discovered that arsenic in combination with an existing leukemia drug work together to target a master cancer regulator.
› Verified 3 days ago